Blood glucose measurement as a modern health-saving technology for patients with diabetes and prediabetes

Self-monitoring of blood glucose levels remains an important clinical tool for managing patients with diabetes, and self-monitoring training is included in all structured patient education programs. Early carbohydrate metabolism disorders (impaired fasting glucose, impaired glucose tolerance) also require regular assessment of target achievement for both blood glucose levels and other health parameters. Innovative digital technologies in diabetology, such as portable glucometers with Bluetooth data transfer and a mobile app, and continuous glycemic monitoring systems, provide additional convenience and advantages in maintaining and interpreting patient outpatient glycemic profile data. Digital healthcare innovations in diabetes allow for greater patient engagement in diabetes mellitus, increase their adherence to therapy and overcome the risks of dysglycemia. This review examines the expansion of the horizons of highly effective and affordable health-saving strategies in patients with diabetes mellitus and prediabetes on the example of glucometry with the use of digitalization as an important and integral tool for disease management. Individualization of goals, display of glycemic trends, convenience and multifunctionality of devices with Bluetooth data transmission and a mobile application allow for better adaptation of patients with diabetes. Trends and innovations in glycemic management highlight the importance of glucometer technology and digitalization in improving patient-doctor interactions to achieve glycemic targets and prevent acute and chronic complications of diabetes.

1. Dedov II, Shestakova MV, Sukhareva OYu, Mokrysheva NG, Andreeva EN, Bezlepkina OB et al. Standards of Specialized Diabetes Care / Edited by Dedov I.I., Shestakova M.V., Sukhareva O.Yu. 12th Edition. Diabetes Mellitus. 2025;28(5S):1–175. (In Russ.) https://doi.org/10.14341/DM20255S.

2. Genitsaridi I, Salpea P, Salim A, Sajjadi SF, Tomic D, James S et al. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol. 2026;14(2):149–156. https://doi.org/10.1016/S2213-8587(25)00299-2.

3. Dedov II, Shestakova MV, Galstyan GR. The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes Mellitus. 2016;19(2):104–112. (In Russ.) https://doi.org/10.14341/DM2004116-17.

4. Petunina NA, Goncharova EV, Terekhova AL. Management of diabetes mellitus. The new period of self-control: detection of glucose trends and patterns. Diabetes Mellitus. 2017;20(6):441–448. (In Russ.) https://doi.org/10.14341/DM8254.

5. Lian X, Liew HL, Lee YS, Lin AY, Goh EYW, Goh CYH et al. Telehealth insulin titration in adults with diabetes: a randomized controlled trial comparing bluetooth-enabled versus traditional glucometers. Front Endocrinol. 2025;16:1724811. https://doi.org/10.3389/fendo.2025.1724811.

6. Rodríguez-Montes OE, Gogeascoechea-Trejo MDC, Bermúdez-Tamayo C. Characteristics of Digital Health Interventions Associated with Improved Glycemic Control in T2DM: A Systematic Review and Meta-Analysis. J Clin Med. 2026;15(3):1123. https://doi.org/10.3390/jcm15031123.

7. Weinstock RS, Aleppo G, Bailey TS, Bergenstal RM, Fisher WA, Greenwood DA, Young LA. The Role of Blood Glucose Monitoring in Diabetes Management. Arlington (VA): American Diabetes Association; 2020. Available at: https://pubmed.ncbi.nlm.nih.gov/33411424.

8. Jawad M, Afaq S, Hussain S, Jamal SF, Haq ZU, Hussain A et al. Effect of digital interventions on adherence to the management of type 1 diabetes mellitus patients: a systematic review. BMC Endocr Disord. 2025;25(1):293. https://doi.org/10.1186/s12902-025-02100-1.

9. Goncharova EV, Petunina NA. Diabetes management and current prospects for self-monitoring of blood glucose. Meditsinskiy Sovet. 2017;(3):17–21. (In Russ.) https://doi.org/10.21518/2079-701X-2017-3-17-21.

10. Alfieri V, Myasoedova VA, Vinci MC, Rondinelli M, Songia P, Massaiu I et al. The Role of Glycemic Variability in Cardiovascular Disorders. Int J Mol Sci. 2021;22(16):8393. https://doi.org/10.3390/ijms22168393.

11. Su G, Mi S, Tao H, Li Z, Yang H, Zheng H, Zhou Y, Ma C. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol. 2011;10:19. https://doi.org/10.1186/1475-2840-10-19.

12. Torimoto K, Okada Y, Mori H, Tanaka Y. Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol. 2013;12:1. https://doi.org/10.1186/1475-2840-12-1.

13. Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int J Mol Sci. 2020;21(5):1835. https://doi.org/10.3390/ijms21051835.

14. Драпкина ОМ, Мокрышева НГ, Шестакова МВ, Лавренова ЕА, Галстян ГР, Дзгоева ФХ и др. Диспансерное наблюдение пациентов с предиабетом врачом­терапевтом в первичном звене здравоохранения. М.: РОПНИЗ; 2024. 36 с. https://doi.org/10.15829/ROPNIZ-d100-2024.

15. Дедов ИИ, Шестакова МВ, Майоров АЮ, Шамхалова МШ, Сухарева ОЮ, Галстян ГР и др. Сахарный диабет 2 типа у взрослых: клинические реко­ мендации. 2022. Режим доступа: https://www.endocrincentr.ru/sites/default/files/specialists/science/clinic-recomendations/saharnyy_diabet_2_tipa_u_vzroslyh.pdf.

16. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327–1334. https://doi.org/10.2337/dc09-9033.

17. Tucker LA. Limited Agreement between Classifications of Diabetes and Prediabetes Resulting from the OGTT, Hemoglobin A1c, and Fasting Glucose Tests in 7412 U.S. Adults. J Clin Med. 2020;9(7):2207. https://doi.org/10.3390/jcm9072207.

18. Zahalka SJ, Galindo RJ, Shah VN, Low Wang CC. Continuous Glucose Monitoring for Prediabetes: What Are the Best Metrics? J Diabetes Sci Technol. 2024;18(4):835–846. https://doi.org/10.1177/19322968241242487.

19. Souza CF, Gross JL, Gerchman F, Leitão CB. Prediabetes: diagnosis, evaluation of chronic complications, and treatment. Arq Bras Endocrinol Metabol. 2012;56(5):275–284. https://doi.org/10.1590/s0004-27302012000500001.

20. He J, Chu N, Wan H, Ling J, Xue Y, Leung K et al. Use of technology in prediabetes and precision prevention. J Diabetes Investig. 2025;16(7):1217–1231. https://doi.org/10.1111/jdi.70057.

21. Li Y, Yang Y, Liu X, Zhang X, Li F. Effectiveness of Telemedicine-Delivered Carbohydrate-Counting Interventions in Patients With Type 1 Diabetes: Systematic Review and Meta-Analysis. J Med Internet Res. 2025;27:e59579. https://doi.org/10.2196/59579.

22. van den Berg N, Schumann M, Kraft K, Hoffmann W. Telemedicine and telecare for older patients – a systematic review. Maturitas. 2012;73(2):94–114. https://doi.org/10.1016/j.maturitas.2012.06.010

23. Klaff L, Shelat P, Zondorak D, Wayland-Smith A, Vernes P, Richardson JM. Accuracy and User Performance of a New Blood Glucose Monitoring System. J Diabetes Sci Technol. 2021;15(6):1382–1389. https://doi.org/10.1177/1932296820974348.

24. Boettcher C, Dost A, Wudy SA, Flechtner-Mors M, Borkenstein M, Schiel R et al.; German/Austrian Diabetes Prospective Documentation Initiative. Accuracy of blood glucose meters for self-monitoring affects glucose control and hypoglycemia rate in children and adolescents with type 1 diabetes. Diabetes Technol Ther. 2015;17(4):275–282. https://doi.org/10.1089/dia.2014.0262.

25. Larina VN. Glucometry and self-control skills as necessary components in the management of a patient with prediabetes in the outpatient settings. FOCUS. Endocrinology. 2023;4(1):23–30. (In Russ.) https://doi.org/10.15829/2713-0177-2023-18.

26. Stuhr A., Pardo S. Impact of real-world use of the CONTOUR®DIABETES app on glycemic control and testing frequency. Poster presented at diabetes technology meeting (DTM) 2018, North Bethesda, Maryland. Available at: https://www.zaloker-zaloker.si/wp-content/uploads/2019/07/Impact-of-real-world-use-of-the-CONTOUR-DIABETES-app-on-glycemic-control-and-testing-frequency.pdf.